Feb 5 (Reuters) -

Medical equipment maker Steris ( STE ) lowered its annual

profit forecast on Wednesday, citing the impact of a stronger

dollar.

The Dublin-based company lowered its fiscal 2025 adjusted

profit to the range of $9.05 to $9.15 per share, from a prior

forecast of $9.05 to $9.25 per share.

"This outlook does not reflect any potential impact from new

tariffs." the company said.

Manufacturers of medical devices have been benefiting from

elevated demand for elective surgical procedures in the United

States, especially among older adults.

Steris ( STE ), which produces surgical instruments, reported

quarterly revenue of $1.37 billion, slightly below analysts'

estimates of $1.38 billion, according to data compiled by LSEG.

The healthcare segment of the company, which provides

sterilization products to healthcare providers, saw its

quarterly revenue rise 7% in the third quarter ended December

31, to $976.0 million.

On an adjusted basis, the company reported a profit of $2.32

per share, which was in line with analysts' expectations.